Human papillomarivus infection among women attending health facilities in the Kingdom of Bahrain

Saudi Medical Journal

Volumn 27, Issue 4, 2006, Pages 487-491

  Hajjaj, Aida A ^a,b   Senok, Abiola C ^a   Al Mahmeed, Ali E ^a   Issa, Abdulla A ^a   Arzese, Alessandra R ^c   Botta, Giuseppe A ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b SALMANIYA MEDICAL COMPLEX   (Bahrain)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; VIRUS DNA;

ADULT; ARTICLE; BAHRAIN; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; DEMOGRAPHY; DNA DETERMINATION; FEMALE; HEALTH CARE FACILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INCIDENCE; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PARITY; POLYGAMY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEXUAL INTERCOURSE; SMOKING; UTERINE CERVIX; VERRUCA VULGARIS; WART VIRUS; MIDDLE AGED; PAPILLOMA VIRUS; PREVALENCE; VIRUS INFECTION;

ADULT; BAHRAIN; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS;

EID: 33645681940     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32 Suppl 1: S16-24.
2. Bosch FX, de Sanjose S. Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 3-13.
3. zur Haunsen H. Papillomaviruses in human cancer. Appl Pathol 1987; 5: 19-24.
4. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003; 16: 1-17.
5. Burkett BJ, Peterson CM, Birch LM, Brennan C, Nuckols ML, Ward BE, et al. The relationship between contraceptives, sexual practices, and cervical human papillomavirus infection among a college population. J Clin Epidemiol 1992; 45: 1295-1302.
6. Daling JR, Madeleine MM, McKnight B, Carter JJ, Wipf GC, Ashley R, et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996; 5: 541-548.
7. Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991; 83: 997-1003.
8. Vermund SH, Kelley KF, Klein RS, Feingold AR, Schreiber K, Munk G, et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991; 165: 392-400.
9. Anonymous. 2002, Cancer incidence report: Executive Board of Health Ministers Council for GCC States, Riyadh, Saudi Arabia: Gulf Centre for Cancer Registration (GCCR); 2005.
10. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer, 2005. CA Cancer J Clin 2005; 55: 31-44.
11. Bollmann R, Bankfalvi A, Griefingholt H, Trosic A, Speich N, Schmitt C, et al. validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany. Oncol Rep 2005; 13: 915-922.
12. Goldie SJ, Kim JJ, Wright TC. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet Gynecol 2004; 103: 619-631.
13. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002; 287: 2372-2381.
14. Astori G, Beltrame A, Pipan C, Raphenon G, Botta GA. PCR-RFLP-detected human papilloma virus infection in a group of senegalese women attending an STD clinic and identification of a new HPV-68 subtype. Intervirology 1999; 42: 221-227.
15. Astori G, Arzese A, Pipan C, de Villiers EM, Botta GA. Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism. Virus Res 1997; 50: 57-63.
16. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994; 170: 1077-1085.
17. Lungu O, Wright TC, Jr., Silverstein S. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes 1992; 6: 145-152.
18. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 278-285.
19. Motti PG, Dallabetta GA, Daniel RW, Canner JK, Chiphangwi JD, Liomba GN, et al. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi. J Infect Dis 1996; 173: 714-717.
20. ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, et al. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992; 51: 515-521.
21. Tonon SA, Picconi MA, Zinovich JB, Nardari W, Mampaey M, Badano I, et al. Human papillomavirus cervical infection in Guarani Indians from the rainforest of Misiones, Argentina. Int J Infect Dis 2004; 8: 13-19.
22. Agnantis NJ, Sotiriadis A, Paraskevaidis E. The current status of HPV DNA testing. Eur J Gynaecol Oncol 2003; 24: 351-356.
23. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350
24. Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity. Sex Transm Dis 1995; 22: 114-118.
25. Gradilone A, Vercillo R, Napolitano M, Cardinali G, Gazzaniga P, Silvestri I, et al. Prevalence of human papillomavirus, cytomegalovirus, and Epstein-Barr virus in the cervix of healthy women. J Med Virol 1996; 50: 1-4.
26. Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia, J Natl Cancer Inst 1992; 84: 394-398.
27. Molijn A, Kleter B, Quint W, van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005; 32 Suppl 1: S43-51.
28. Woodman CB, Colins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357: 1831-1836.